| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,615 |
6,306 |
$1.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,233 |
3,918 |
$1.49M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,785 |
2,549 |
$1.34M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,674 |
2,035 |
$457K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
537 |
525 |
$357K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,846 |
1,782 |
$294K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,880 |
2,466 |
$293K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,490 |
1,641 |
$265K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,668 |
2,392 |
$167K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,077 |
1,797 |
$149K |
| 71046 |
Radiologic examination, chest; 2 views |
1,510 |
1,445 |
$143K |
| 70450 |
Computed tomography, head or brain; without contrast material |
451 |
436 |
$133K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
789 |
761 |
$127K |
| 80053 |
Comprehensive metabolic panel |
7,766 |
6,895 |
$127K |
| 87631 |
|
638 |
619 |
$119K |
| 71045 |
Radiologic examination, chest; single view |
1,708 |
1,579 |
$115K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,484 |
1,156 |
$115K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
567 |
454 |
$99K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,925 |
6,131 |
$78K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
432 |
419 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,432 |
2,081 |
$67K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,710 |
627 |
$65K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
806 |
753 |
$53K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
374 |
306 |
$49K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,552 |
1,188 |
$46K |
| 73562 |
|
312 |
283 |
$45K |
| 84484 |
|
2,185 |
1,751 |
$39K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,090 |
1,065 |
$27K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,164 |
1,118 |
$26K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
354 |
331 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
940 |
922 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
3,896 |
3,589 |
$21K |
| 83690 |
|
1,933 |
1,774 |
$20K |
| 73630 |
|
176 |
149 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
80 |
80 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,528 |
1,426 |
$17K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
38 |
38 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
267 |
252 |
$16K |
| 80306 |
|
515 |
488 |
$15K |
| 81001 |
|
2,359 |
2,203 |
$15K |
| 73610 |
|
89 |
82 |
$14K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
909 |
752 |
$14K |
| 72110 |
|
77 |
76 |
$12K |
| 83605 |
|
832 |
742 |
$12K |
| J3490 |
Unclassified drugs |
2,550 |
1,190 |
$10K |
| 73130 |
|
89 |
81 |
$9K |
| 83880 |
|
272 |
253 |
$8K |
| 81025 |
|
595 |
575 |
$7K |
| 83735 |
|
891 |
834 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
542 |
537 |
$6K |
| 85027 |
|
548 |
510 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
168 |
168 |
$6K |
| 81003 |
|
940 |
906 |
$5K |
| 82077 |
|
279 |
262 |
$5K |
| 85610 |
|
678 |
599 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,170 |
970 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
27 |
27 |
$4K |
| 80061 |
Lipid panel |
253 |
250 |
$4K |
| 87040 |
|
251 |
196 |
$4K |
| 97161 |
|
77 |
69 |
$3K |
| 87081 |
|
347 |
342 |
$3K |
| 87077 |
|
283 |
261 |
$3K |
| 84439 |
|
274 |
270 |
$3K |
| 73030 |
|
27 |
25 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
150 |
146 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
180 |
172 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
920 |
862 |
$3K |
| 86140 |
|
366 |
351 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
27 |
25 |
$2K |
| 97162 |
|
24 |
24 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
12 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
24 |
24 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
91 |
80 |
$2K |
| 85379 |
|
101 |
98 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
17 |
$1K |
| 36000 |
|
116 |
112 |
$1K |
| 87186 |
|
104 |
93 |
$1K |
| 73110 |
|
12 |
12 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
634 |
594 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
24 |
24 |
$1K |
| 85018 |
|
290 |
255 |
$976.95 |
| 96376 |
|
19 |
12 |
$942.14 |
| 82805 |
|
12 |
12 |
$875.19 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
192 |
180 |
$802.51 |
| 90715 |
|
25 |
25 |
$590.01 |
| 97035 |
|
28 |
13 |
$579.13 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32 |
25 |
$487.22 |
| 87650 |
|
13 |
13 |
$413.45 |
| 82550 |
|
40 |
38 |
$397.96 |
| 84703 |
|
26 |
26 |
$358.87 |
| 87430 |
|
15 |
15 |
$340.71 |
| 82962 |
|
85 |
40 |
$292.32 |
| 85652 |
|
28 |
28 |
$220.89 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
34 |
33 |
$157.74 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
58 |
55 |
$129.81 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
15 |
$128.69 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
84 |
75 |
$118.58 |
| 82043 |
|
13 |
12 |
$110.41 |
| 82570 |
|
13 |
12 |
$96.17 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
34 |
34 |
$58.46 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$8.79 |